Ixazomib | compare suppliers & send inquiries for free
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
MOQ: 1 kg
Shandong Octagon Chemicals Limited
MOQ: 1 g
Looking for Ixazomib 1072833-77-2?
You can find a short description about Ixazomib here. Ixazomib a second generation proteasome inhibitor (PI) and the first oral PI approved by the FDA in November 2015 for multiple myeloma treatment in combination with 2 other therapies (lenalidomide and dexamethasone) for patients who have received at least 1 prior therapy. It was found to have similar efficacy to bortezomib (the first PI approved for multiple myeloma therapy) in the control of myeloma growth and prevention of bone loss. Ixazomib citrate is marketed by Takeda Pharmaceuticals under the brand name Ninlaro, which is a prodrug that becomes quickly converted to its active metabolite, ixazomib, after administration.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Ixazomib manufacturers | traders | suppliers
We have 2 companies offering Ixazomib from 2 different countries.
Get in contact with the supplier of your choice:
- Chunghwa Chemical Synthesis & Biotech Co., Ltd. from Taiwan
- Shandong Octagon Chemicals Limited from China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.